Results 151 to 160 of about 17,612 (170)
Some of the next articles are maybe not open access.
Complications of Autoimmune Hemolytic Anemia
Hematology/Oncology Clinics of North America, 2022Autoimmune hemolytic anemia (AHIA) is the group of acquired autoimmune conditions resulting from the development of autologous antibodies directed against autologous red blood cell antigens resulting in red cell lysis. Beyond the presence, severity, and duration of hemolysis which can lead to symptomatic anemia, additional complications at presentation
Surbhi, Shah, Leslie, Padrnos
openaire +2 more sources
Autoimmune hemolytic anemia: A history*
Transfusion Medicine Reviews, 2000UTOIMMUNE HEMOLYTIC anemia (AIHA) is an acquired immunoIogic disease in which the patient's red blood cells (RBCs) are selectively attacked and destroyed (hemolyzed) by autoantibodies produced by the patient's own immune system. These patients generally display the common symptoms of anemia: weakness, pallor, fatigue, and jaundice.
John Freedman, Peter Mack
openaire +3 more sources
Autoimmune Hemolytic Anemia in Scleroderma
JAMA: The Journal of the American Medical Association, 1971In a case of scleroderma and autoimmune hemolytic anemia, azathioprine treatment resulted in complete remission of the hemolysis despite the persistence of positive direct and indirect antiglobulin test. There were no beneficial results of the therapy on the underlying connective tissue disorder. Complications of azathioprine treatment encountered were
Burton Sack, David S. Rosenthal
openaire +3 more sources
Autoimmunization and the Autoimmune Hemolytic Anemias.
Archives of Internal Medicine, 1970Comparison is inevitable with part 2 of The Haemolytic Anaemias: The Autoimmune Haemolytic Anaemias , 1962, by John Dacie which, as they say in show biz, is a tough act to follow. Dacie brought to his task the long experience of a gifted and methodical hematologist.
openaire +2 more sources
AUTOIMMUNE HEMOLYTIC ANEMIA IN CHILDREN
Pediatric Hematology and Oncology, 2007The clinical and hematological profile and treatment outcome of children with warm autoimmune hemolytic anemia (AIHA) were assessed using retrospective case record analysis. There were 26 (17 idiopathic; 9 secondary) patients with a median age of 11 years. Pallor (100%), fever (39%), and jaundice (59%) were the main presenting complaints.
Ved Prakash Choudhry +5 more
openaire +3 more sources
Geoepidemiology of autoimmune hemolytic anemia
Autoimmunity Reviews, 2010Autoantibodies against red blood cell antigens are considered the diagnostic hallmark of AIHA: Direct antiglobulin test (DAT) completed by cytofluorometry and specific diagnostic monoclonal antibodies (mAbs) allow for a better understanding of autoimmune hemolytic anemia (AIHA) triggers. Once B-cell tolerance checkpoints are bypassed, the patient loses
Urs E. Nydegger, Jean-Francois Lambert
openaire +3 more sources
Treatment of Autoimmune Hemolytic Anemia
Seminars in Hematology, 2005The appropriate therapy of autoimmune hemolytic anemia (AIHA) is dependent on the correct diagnosis and classification of this family of hemolytic disorders. Although the majority of cases are warm AIHA, there are several distinct types of cold AIHA and a number of drug-induced etiologies of AIHA, which must be investigated to determine if stopping a ...
Paul M. Ness, Karen E. King
openaire +2 more sources
Autoimmunization and the Autoimmune Hemolytic Anemias
JAMA: The Journal of the American Medical Association, 1969This is an unusual book in both concept and presentation. The first half presents the problem of autoimmune hemolytic anemias in a clinical perspective. Material from the vast literature is interwoven with a very substantial personal clinical experience, more than 200 cases, that the author observed during an eight-year period.
openaire +2 more sources
2009
Publisher Summary This chapter reviews autoimmune hemolytic anemias (AIHA) which includes a group of disorders where autoantibodies are directed against red blood cell (RBC) membrane antigens. This results in shortened RBC survival through activation of the complement system and removal within the reticuloendothelial system.
Christopher D. Hillyer, Beth H. Shaz
openaire +2 more sources
Publisher Summary This chapter reviews autoimmune hemolytic anemias (AIHA) which includes a group of disorders where autoantibodies are directed against red blood cell (RBC) membrane antigens. This results in shortened RBC survival through activation of the complement system and removal within the reticuloendothelial system.
Christopher D. Hillyer, Beth H. Shaz
openaire +2 more sources
Archives of Internal Medicine, 1977
Autoimmune hemolytic anemia (AHA) may be either primary (ie, "idiopathic," one third of all patients) or secondary (ie, associated with underlying illness, two thirds of all patients). A positive Coombs antiglobulin test is the most important criterion for diagnosis of AHA, and characterization of RBC coating (as to whether it is by IgG alone, by IgG ...
Hugh Chaplin, Louis V. Avioli
openaire +3 more sources
Autoimmune hemolytic anemia (AHA) may be either primary (ie, "idiopathic," one third of all patients) or secondary (ie, associated with underlying illness, two thirds of all patients). A positive Coombs antiglobulin test is the most important criterion for diagnosis of AHA, and characterization of RBC coating (as to whether it is by IgG alone, by IgG ...
Hugh Chaplin, Louis V. Avioli
openaire +3 more sources